Fitness Trends Cancer Tumor Profiling Market | Page 2

EpiVax Inc. launched EpiVax Oncology Inc., which is an approach for precision cancer
immunotherapy in 2017. EpiVax used molecular profiling through Next-Generation Sequencing
(NGS) to produce therapeutic vaccines for cancer.
Personal Genome Diagnostics Inc. launched CancerSELECT 125 test for pan-cancer tumor
profiling in 2016. CancerSELECT 125 identify tumor specific functional sequence mutation in
multiple cancer types with high accuracy.
Report includes chapters which deeply display the following deliverable about industry :
• Cancer/Tumor Profiling Market Research Objective and Assumption
• Cancer/Tumor Profiling Market Purview - Report Description, Executive Summary, and
Coherent Opportunity Map (COM)
• Cancer/Tumor Profiling Market Dynamics, Regulations, and Trends Analysis - Market
Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system
Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Cancer/Tumor Profiling Market, By Regions
• Cancer/Tumor Profiling Market Competition by Manufacturers including Production, Share,
Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Cancer/Tumor Profiling Market Manufacturers Profiles/Analysis including Company Basic
Information, Manufacturing Base and Its Competitors.
• Cancer/Tumor Profiling Market Manufacturing Cost Analysis including Key Raw Materials and
Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Cancer/Tumor Profiling Market Forecast including Production, Consumption, Import and
Export Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Some of the major key players operating in the global cancer profiling market include Proteome
Sciences PLC, Life Technologies Corporation, Illumina, Inc., BioTheranostics, RiboMed
Biotechnologies Inc., NeoGenomics Laboratories, Oxford Gene Technology Ltd., Genomic Health
Inc., Agendia, and Oncopath Laboratories.